A new light-activated catalyst enables deracemization via carbon–halogen bond cleavage—the first of its kind targeting heteroatom bonds—offering a streamlined route to chiral pharmaceuticals

E. H. Tiekink, R. Verdijk, T. A. Hamlin, F. M. Bickelhaupt used quantum chemistry to show that hydrogen-bonding organocatalysts speed up the Diels–Alder reaction

Dr. Tim Kinzel, Executive Director of the GDCh, speaks here about the importance of volunteer engagement, collaboration, and addressing the changing needs of society as a central task of modern chemical societies

A mild, efficient system for selectively deprotecting and modifying N-heterocycles in a single step